Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “Labels”
AN OPEN-LABEL, ACUTE CLINICAL TRIAL TO ASSESS THE LEVEL OF KETONE PRODUCTION FOLLOWING CONSUMPTION OF AVELA™ (R)-1,3-BUTANEDIOL IN AN ADULT POPULATION
ClinicalTrials.gov study NCT05384106. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open Label, Randomized-controlled Trial to Assess Efficacy Safety of HYALODISC With Physical Exercise Program
ClinicalTrials.gov study NCT04757038. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study To Assess Effects Of PF-04958242 On Bold Functional Magnetic Resonance Imaging During Working Memory Activation And Arterial Spin Labeling At Rest In Healthy Subjects
ClinicalTrials.gov study NCT01365338. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type Psoriasis
ClinicalTrials.gov study NCT00725348. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Investigate ADME of 14C Labeled SLV334 After an i.v. Infusion
ClinicalTrials.gov study NCT01044524. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label,Phase II Trial of MAB Dose Escalation OF Bicalutamide For Biochemical Failure In Prostate Cancer Patients.
ClinicalTrials.gov study NCT00554086. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination.
ClinicalTrials.gov study NCT06806995. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)
ClinicalTrials.gov study NCT02130999. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With
ClinicalTrials.gov study NCT06877533. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinoma
ClinicalTrials.gov study NCT03061643. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy
ClinicalTrials.gov study NCT01411189. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-label Study on the Clinical Efficacy of tDCS Intervention in PD
ClinicalTrials.gov study NCT06566313. IPD Sharing: NO. Countries: 1. Publications: 0.
Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder
ClinicalTrials.gov study NCT00325286. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.
ClinicalTrials.gov study NCT06836505. IPD Sharing: NO. Countries: 1. Publications: 0.
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery
ClinicalTrials.gov study NCT04888975. IPD Sharing: NO. Countries: 1. Publications: 0.
Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)
ClinicalTrials.gov study NCT06327100. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers
ClinicalTrials.gov study NCT05204147. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26
ClinicalTrials.gov study NCT04746638. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Pharmacokinetic Study of SAR302503 in Subjects With Renal Impairment
ClinicalTrials.gov study NCT01763190. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia
ClinicalTrials.gov study NCT05535920. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.